Supercharge new treatment development.

We map the complete landscape of KOLs, DOLs, and PAGs across every therapeutic area, then accelerate clinical trial enrollment through targeted digital recruitment.

Trusted by innovative biopharma

Terns
Daiichi-Sankyo
Amgen
Mustang Bio
Otsuka
Biogen
Marea
Synlogic
Real Chemistry
Syneos Health
Sermo
Tolmar
Johnson & Johnson
Havas Group
Apellis
UCB
Avidity Biosciences
Boston Scientific
Ironwood
Mitsubishi Tanabe
Terns
Amgen
Daiichi-Sankyo
Mustang Bio
Otsuka
Synlogic
Havas Group
Marea
Real Chemistry
Syneos Health
Johnson & Johnson
Biogen
Tolmar
Apellis
UCB
Boston Scientific
Avidity Biosciences
Ironwood
Sermo
Mitsubishi Tanabe
Horizon

What we do

PRE-CLIN PHASE 1 PHASE 2 PHASE 3 LAUNCH

Adnexi is a technology platform built to accelerate biopharma treatment development and launch. We map the experts and influence networks shaping your therapeutic area, then take a proactive approach to recruiting eligible patients directly into your clinical trials. One platform, from landscape intelligence to enrolled patient.

PRE-CLINICAL PHASE 1 PHASE 2 PHASE 3 LAUNCH
Expert intelligence llama mascot

Expert intelligence

Our platform maps every KOL, DOL, and advocacy group across therapeutic areas, giving your team a complete, daily-updated picture of who matters and why.

Precision recruitment llama mascot

Precision recruitment

From digital ad to enrolled patient, our recruitment engine handles the full pipeline, prescreener, site matching, fraud detection, and real-time tracking.

Influence mapping llama mascot

Influence mapping

We trace every influence pathway, from advocacy groups to prescribing physicians, using proprietary data not available on any other platform.

Case studies

See how we help biopharma accelerate treatment development

Explore our collection of case studies and learn how Adnexi has helped biopharma and medical device companies accelerate treatment development and launch.

Rare Oncology

Patient Advocacy & DOL Engagement for Trial Awareness

Adnexi identified and engaged patient advocacy groups and digital opinion leaders to drive trial awareness in a rare oncology indication.

Read case study
Ultra Rare Disease

Phase 3 Clinical Trial Enrollment Acceleration

Adnexi's proprietary platform accelerated clinical trial enrollment through targeted digital screening and site matching for an ultra rare disease program.

Read case study
Neurodegenerative Disease

Phase 2 Patient Lead Generation Program

The Adnexi platform powered a patient lead generation program to accelerate trial enrollment for a Phase 2 study in neurodegenerative disease.

Read case study
Check Out All Case Studies